Gal·la Pericot, R&D Manager at SOM Biotech, attended the European Conference on Recent Advances in Lysosomal Diseases, which took place on 24-25 October 2019 in London, UK.

The main objective of the conference was sharing of innovative knowledge on the development of new therapeutic modalities for treating disorders linked to the lysosomal storage in the cells, which contribute to the development of some of the main orphan diseases, as the Gaucher, the Fary, the Pompe, and the Hunter Syndromes. Knowledge about Lysosomal Diseases obtained at the conference will serve to SOM Biotech for the further advancement of its projects in this area.

SUBCRIBE TO OUR NEWSLETTER

    Name*
    Email*


    I confirm that by completing this form I have used only personal data about myself and that they are true and up-to-date.
    SOM INNOVATION BIOTECH, S.A. is responsible for the processing of my personal data to manage the newsletter service requested through the form, as well as to track the receipt of these through tracking technologies. The Privacy Policy tells me how I can exercise my rights of access, rectification, deletion, limitation, portability and opposition.